Toso et al. [72] from Switzerland reported that, although the recurrence rate was slightly higher in the downstaging group, there was no difference in survival between the downstaging group and the control group (patients who remained inside the LT criteria) when the tumor burden was limited to TTV ≤115 cm3 and AFP ≤400 ng/mL. This evidence concerns the gene AFP and neoplasm.